Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Explore various ways to grow wealth with low risk that can help you achieve financial security. Start making informed investment choices today.
27,305 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
The International Energy Agency announced a historic emergency stock release of 400 million barrels, aiming to cool e...
XRP ETFs have seen a wave of redemptions in March, yet industry analysts say the funds’ resilience remains intact as ...
As markets wobble in 2026, five stalwarts stand out for reliable income and resilience. Here are the safest dividend ...
Meta Platforms is considering cutting up to 20% of its workforce to fund AI infrastructure through 2028. The move mir...
Market bifurcation put Meta Platforms and Netflix on opposite growth tracks in early 2026. One path could double asse...
Playnance launches the G Coin presale on March 18, positioning the token as the utility layer for an ecosystem with h...
Two tobacco giants show divergent paths over 10 years, with dividend income boosting returns for both. Here's what ha...
SoundHound AI reports a 59% rise in Q4 revenue and a narrowed EBITDA loss, yet the stock has fallen year-to-date amid...
Disney faces a pivotal year as it retools streaming and parks. This disney stock price prediction outlines scenarios ...
Apollo Global Management posted strong 2025 revenue and raised its dividend, but the stock has fallen as private cred...
Oil prices pressed higher on March 26, 2026, nearing the mid-$100s per barrel. The move highlights how current price ...